Utama › Myasthenia Gravis › South Carolina
Kajian klinikal Myasthenia Gravis di South Carolina
7 kajian untuk Myasthenia Gravis sedang mencari peserta di lokasi di South Carolina.
Bandar di South Carolina
Teks kajian rasmi (Bahasa Inggeris)
A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)
- TG Therapeutics Investigational Trial Site, Greenville
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07673744Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- Clinical Trials of South Carolina - Charleston, Charleston
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06463587A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
- Clinical Trials of South Carolina - Neurology, Charleston
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Sep 2026 · NCT07501702Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1030, Charleston
- Site Number - 1015, Charleston
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 30 Jul 2026 · NCT07039916A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Medical University of South Carolina, Charleston
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT04951622A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
- Medical University of South Carolina, Charleston
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Feb 2026 · NCT06298565Vitaccess Real MG Registry
- Medical University South Carolina, Charleston
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jul 2025 · NCT06064461Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.